Guidance

Current measures to reduce the risk of vCJD transmission by blood

SaBTO summary of measures currently in place in the UK to reduce the risk of transmitting variant Creutzfeldt-Jakob disease (vCJD) via blood.

• From: Department of Health and Social Care
• Published: 20 December 2013
• Last updated: 26 February 2015 — See all updates

This publication was withdrawn on 9 September 2019

This guidance was withdrawn on 9 September 2019 because it is out of date. It has been superseded by: https://www.gov.uk/government/publications/risk-reduction-measures-for-variant-creutzfeldt-jakob-disease-pcwg-report

Documents

Measures currently in place in the UK to reduce the potential risk of transmitting variant Creutzfeldt-Jakob disease via blood

PDF, 171 KB, 3 pages

Details

Summary published by the Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO) that sets out the range of measures currently being taken in the UK to reduce the potential risk of transmitting vCJD by a transfusion of blood or blood products.

Published 20 December 2013
Last updated 26 February 2015 + show all updates

1. 26 February 2015

   Updated guidance published.

2. 20 December 2013

   First published.